Drug name (Generic)

Ulipristal Acetate

Pharmacologic class

SPRM (Selective Progesterone Receptor Modulator)

Chemical formula

C₃₀H₃₇NO₄

Indication

Ulipristal acetate (UPA) is indicated for both preoperative and intermittent treatment of moderate and even severe symptoms of the uterine myomas in an adult female of reproductive age.

Pharmacology

Ulipristal acetate (UPA) acts as a progesterone agonist or antagonist depending upon the target tissues, and presence or absence of progesterone. Its primary pharmacodynamic property is to block reversibly at the progesterone receptor at its target tissues (cervix hypothalamus, ovaries, uterus). Ulipristal acetate pertains to the family of drugs known as selective progesterone receptor modulators (SPRMs).

Dosage/Dosage form

5 mg OD/tablets

Route of administration

Oral